Background In large rotator cuff tears, retraction of the supraspinatus muscle creates suprascapular nerve traction and compression. However, suprascapular nerve transection, when used in previous models, is different from chronic compression of the suprascapular nerve in patients. To define the role of suprascapular nerve chronic injury in rotator cuff muscle atrophy and fatty infiltration, we developed a novel reversible suprascapular nerve compression mouse model. Questions/purposes We asked: (1) Can suprascapular nerve injury be induced by compression but reversed after compression release? (2) Can muscle fatty infiltration be induced by suprascapular nerve compression and reversed after compression release? (3) Is white fat browning involved in fatty infiltration resorption? Methods Mice in a common strain of C57BL/6J were randomly assigned to suprascapular nerve transection (n = 10), nerve compression (n = 10), nerve compression and release (n = 10), or sham control (n = 10) groups. To study the role or white fat browning on muscle fatty infiltration, additional UCP1 reporter mice (n = 4 for nerve compression and n = 4 for nerve compression release) and knockout mice (n = 4 for nerve compression and n = 4 for nerve compression release) were used. Nerve injury was testified using osmium tetroxide staining and neural muscular junction staining and then semiquantified by counting the degenerating axons and disrupted junctions. Muscle fatty infiltration was evaluated using Oil Red O staining and then semiquantified by measuring the area fraction of fat. Immunofluorescent and Oil Red O staining on UCP1 transgenic mice was conducted to testify whether white fat browning was involved in fatty infiltration resorption. Ratios of UCP1 positively stained area and fat area to muscle cross-section area were measured to semiquantify UCP1 expression and fatty infiltration in muscle by blinded reviewers. Analysis of variance with Tukey post hoc comparisons was used for statistical analysis between groups. Copyright Ó 2018 by the Association of Bone and Joint Surgeons. Unauthorized reproduction of this article is prohibited.
Introduction
Rotator cuff tears are the most common tendon injury in the adult population, affecting at least 10% of people older than 60 years of age in the United States [13] . Accumulating evidence suggests that suprascapular nerve entrapment and traction after large or massive rotator cuff tears are involved in supraspinatus and infraspinatus muscle atrophy and fatty infiltration, which are important factors responsible for failed tendon repairs [5, 27, 35] . Thus, defining the role of suprascapular nerve neuropathy in supraspinatus and infraspinatus muscle atrophy and fatty infiltration is critical to understanding the mechanisms of secondary muscle degeneration after rotator cuff tears and the development of a treatment strategy to improve rotator cuff muscle function after rotator cuff repair. Currently, it is rare for interventions to be performed on the suprascapular nerve at the time of rotator cuff repair, and understanding how the nerve directly reacts to traction and compression may change clinical practice or improve muscle quality (and perhaps clinical outcomes) after rotator cuff repair.
We have previously developed rodent models of massive rotator cuff tears with transection of the suprascapular nerve to study the mechanisms of muscle atrophy and fatty infiltration with suprascapular nerve injury [30, 31] . In those models, we observed muscle atrophy and fatty infiltration after suprascapular nerve transection, suggesting a critical role of suprascapular nerve neuropathy involved in muscle pathology after massive rotator cuff tears. We subsequently found that suprascapular nerve transection and rotator cuff transection use different pathways in rotator cuff muscle degeneration [20] . Our models were well accepted by the field and have been used by multiple groups in their studies [2, 16, 26, 38] . However, those models are limited by the fact that the acute transection does not completely simulate chronic compression of the suprascapular nerve injury seen in patients with rotator cuff tears.
In humans and many other vertebrate animals including mice, there are two types of fat with distinct phenotypes and functions: white fat to store energy and brown fat to generate heat. Recent studies have discovered some white fat-like fat is actually an interchangeable form, named beige or brite fat, which can become brown-like fat in response to appropriate stimuli [22, 23, 28, 29] . This process, termed "white fat browning," is mediated by uncoupling protein 1 (UCP1) to dissipate energy. "Browning of white fat" has becoming a potential therapeutic intervention to treat obesity and metabolic diseases in recent years [18, 24] . However, it remains unknown if brown or beige fat is involved in muscle fatty infiltration.
In this study, we hypothesized that isolation and ligation of the suprascapular nerve would result in marked muscle atrophy and fatty infiltration and that release of the nerve would result in muscle quality improvement as measured by functional outcomes (gait analysis) and histologic analysis. We further suggested that beige fat, as determined by UCP1 expression, would be a key factor in the ability of the muscle to decrease fat after nerve release. We developed a novel mouse model of chronic suprascapular nerve compression.
Specifically, using that model, we asked: (1) Can suprascapular nerve injury be induced by compression but reversed after compression release? (2) Can fatty infiltration of muscle be induced by suprascapular nerve compression and reversed after compression release? (3) Is white fat browning involved in fatty infiltration resorption?
Materials and Methods

Experimental Overview
Eight-week-old adult mice were used in this study. These included 45 female C57BL/6J mice (Jackson Laboratory Inc, Sacramento, CA, USA, stock # 000664), eight UCP1 reporter male mice (FVB/N-Tg[Ucp1-luc2,-tdTomato] 1Kajim/J, JAX stock # 026690), and eight UCP1-KO female mice (129S-Ucp1 tm1Kz /J, JAX stock # 017476) that Dr Shingo Kajimura of the University of California at San Francisco provided as gifts. Only female C57B/L6J mice were used in the present study, because no sex differences were found in a pilot study. In UCP1 reporter mice, the UCP1 reporter gene was inserted into the Y chromosome.
Thus, only male UCP1 reporter mice were used. Both male and female UCP1 knockout mice were used in this study. Mice were randomized into sham and experimental groups. According to our preliminary experiment, power analysis was performed using an estimated 15% difference in area fraction of fat in muscle between the sham group and the nerve compression group. With b = 0.80 and a = 0.05, we determined that four mice per group would be sufficient to demonstrate a difference of 18% in muscle fat area fraction between the sham and nerve compression groups, which is the effect size we considered clinically important. For the C57BL/6J mice, 10 animals underwent unilateral suprascapular nerve transection to establish denervation of the supraspinatus and infraspinatus (five mice for histologic staining and five mice for quantitative polymerase chain reaction analysis, 10 mice underwent unilateral suprascapular nerve compression surgery, 10 mice underwent unilateral suprascapular nerve compression for 6 weeks and then release, 10 mice underwent unilateral sham surgery, and five mice served as baseline controls for gait analysis). For UCP1 reporter mice, four UCP1 (-/-) (knockout) and four UCP1 (+/+) (wild-type control for UCP1 KO) mice underwent unilateral suprascapular nerve compression for 2 weeks. Another four UCP1 (-/-) and four UCP1 (+/+) mice underwent unilateral suprascapular nerve compression for 2 weeks and then release (Fig. 1) .
Conditions and diet were identical for all animals. Mice were housed and cared for in accordance with the New Zealand Animal Welfare Act [34] . All procedures were approved by our institutional animal care and use committee.
The primary outcome was the fatty infiltration in supraspinatus and infraspinatus muscles. Secondary outcomes were the UCP1 expression in supraspinatus and infraspinatus muscles, nerve regeneration, wet muscle weight, gene expression, gait analysis, and muscle fibrosis.
Surgical Procedures
For the suprascapular nerve transection surgery, after general anesthesia by 3% isoflurane, the right-sided suprascapular nerve was transected as described previously [30] . For the suprascapular nerve compression and release, after the skin incision, the trapezius muscle was separated to expose the suprascapular nerve. After it was identified, the suprascapular nerve was wrapped in a sterile 1 mm x 1 mm x 50-mm polyethylene sheet to form a tube (Fisher Scientific™, Waltham, MA, USA) at the site immediately after it was derived from the superior trunk of the bronchial plexus. The tube was ligated at each end with 7-0 nylon sutures. The sutures and polyethylene tube were removed at 2 weeks or 6 weeks after compression in some animals (Fig. 2) . The trapezius muscles and skin were closed at both suprascapular nerve compression and release procedures. For the sham surgery, the skin and muscle incisions were performed, the suprascapular nerve was identified, and the muscle and skin were then closed.
Gait Analysis
DigiGait TM (Mouse Specifics Inc, Quincy, MA, USA) analysis was conducted to measure shoulder function at the day of harvest as described previously [6] . All animals were weighed to confirm that there were no statistical differences among all groups before being euthanized (data not shown). All mice walked 10 cm/s for 10 seconds on the DigiGait system. Stride length, stance width, and paw area at peak stance were chosen for the parameters to assess forelimb function [9, 25] .
Sample Harvesting, Wet Muscle Weight, and Histology
After the mice were euthanized, we harvested the bilateral supraspinatus (SS) and infraspinatus (IS) muscles. For assessing muscle atrophy, we measured the wet weight of bilateral supraspinatus and infraspinatus muscles immediately after harvesting. The percent change of wet muscle weight was measured using the following equation:
After weighing, the supraspinatus and infraspinatus muscles were mounted on cork disks (Fisher Scientific) with 10% w/v tragacanth gum (Sigma-Aldrich, St Louis, MO, USA) and flash frozen in liquid nitrogencooled 2-methylbutane followed by a 10-mm cryosection for muscle histology staining or 20-mm cryosection for neuromuscular junction staining. Masson trichrome (American MasterTech, Lodi, CA, USA) and Oil Red O (Sigma-Aldrich) staining were conducted to assess the fibrosis and fatty infiltration in the muscle. A segment of the suprascapular nerve distal to the compression site was also harvested to evaluate the nerve injury and recovery after compression/release. After fixing using 4% paraformaldehyde (Fisher Scientific) overnight, the suprascapular nerve was stained with 2% osmium tetroxide (Sigma-Aldrich) for 120 minutes, dehydrated in grading ethanol and xylene, embedded in paraffin, and then divided into 7-mm sections as previously described [19] .
Immunofluorescence Staining
Neuromuscular junction staining for C57BL/6J mice was performed as previously described [4] . Samples were fixed in 4% paraformaldehyde for 30 minutes, rinsed in phosphatebuffered saline (PBS) for 10 minutes three times, placed in 0.1 M glycine (Fisher Scientific, diluted in PBS) for 30 minutes, and washed again for 3 x 10 minutes in PBS. They were then immersed in 100% methanol for 5 minutes at -20°C , rinsed for 3 x 10 minutes in PBS, and covered with blocking solution (0.2% Triton X-100, 2% bovine serum albumin in PBS) for 1 hour at room temperature. Primary antibodies (Developmental Studies Hybridoma Bank, Iowa City, IA, USA) against neurofilament (NF-2H3, diluted 1: 250) and synaptic vesicle protein 2 (SV2, diluted 1:250) were diluted in a block mix and added to the sections for overnight incubation at 4°C. The next day, samples were rinsed in PBS for 3 x 10 minutes and incubated in a mixture containing rhodamine conjugated alpha-bungarotoxin (T0195, SigmaAldrich, diluted 1:200) and FITC-conjugated donkey antimouse IgG (ab150109, Abcam, Burlingame, CA, USA; diluted 1:250) at room temperature for 120 minutes. Sections were then rinsed for 20 minutes in PBS and mounted with coverslips using VectaShield with DAPI (H-1200; Vector Laboratories, Burlingame, CA, USA).
For UCP1 reporter mice, sections were fixed in 4% paraformaldehyde for 30 minutes, rinsed in PBS for 30 minutes, incubated with blocking solution (the same as previously described) for 60 minutes, and subsequently treated with the primary antibody (anti-Laminin, L9393, Sigma-Aldrich, 1:500 diluted in blocking solution) at 4°C overnight. After a PBS rinse for 3 x 10 minutes, the sections were incubated with secondary antibody (ab150073, Alexa Fluor 488-and conjugated antirabbit IgG) for 120 minutes. After a PBS rinse for 2 x 10 minutes, the slides were mounted with coverslips using VectaShield with DAPI.
Image Capture and Quantification
Histology images were observed on an optical microscope (Axio Imager; Zeiss, Oberkochen, Germany), and fluorescent images were acquired using an Axio Observer D1 fluorescence microscope. Pictures were analyzed using image analysis software (ImageJ; National Institutes of Health, Bethesda, MD, USA). All pictures were assessed by two blinded reviewers (ZW, KJ). For osmium staining, an average of 700 axons per group was evaluated, and the ratio of axons with abnormal myelin (myelin reduplication, splitting of the myelin sheath, and detachment of the myelin sheath from the axon) was calculated by dividing the number of abnormal axons by the number of entire axons [3] . For neuromuscular junction staining, we evaluated 212 to 230 neuromuscular junctions per group. We calculated the ratio of disrupted neuromuscular junctions (acetylcholine receptor with absence of neurofilament) by dividing the number of disrupted neuromuscular junctions by the number of total neuromuscular junctions [4] . Crosssection area was measured with muscle fibers in five randomly selected areas on sections from the midbelly of the supraspinatus and infraspinatus muscles. The area fraction of fibrosis was calculated by dividing the area of Aniline Blue staining collagenous fibrotic area by the entire sample area. Similarly, the area fraction of fatty infiltration was assessed by dividing the area of Oil Red O staining fat area by the entire sample area [30, 31] . To evaluate UCP1 expression in muscle, we calculated the ratio of UCP1 area by dividing the UCP1 stained area by the entire sample area.
Reverse Transcription-Polymerase Chain Reaction
Total RNA for the supraspinatus/infraspinatus pooled muscle samples was extracted using Trizol reagent (Fisher Scientific) according to the instructions. The Transcriptor First Strand cDNA Synthesis Kit (Roche Applied Bioscience Inc, Indianapolis, IN, USA) was applied to synthesize cDNA. We performed reverse transcription-polymerase chain reaction (RT-PCR) to quantify the expression of Atroin-1, Murf-1, a-SMA, collagen-1a, collagen-3a, PPAR-g1, PPAR-g2, C/EBP-a, and Adipoq using SYBR Green Detection and an Applied Biosystems Prism 7900HT detection system (Applied Biosystems Inc, Foster City, CA, USA). Sequences of the primers for target genes were summarized ( Table 1 ). The expression level of each gene was normalized to that of the housekeeping gene of S26. Fold changes relative to sham controls were calculated using DDCT.
No animal died; no skin wound infections or other unexpected adverse events were observed in this study.
Statistical Analysis
Analyses of variance with Tukey post hoc comparisons were used to calculate the difference in the ratio of degenerating axons, ratio of injured neuromuscular junction, percent wet muscle weight change, area fraction of collagen, area fraction of fat, gene expression, gait analysis, and ratio of UCP1 area among all groups. For the 6-week nerve compression and release group, Pearson correlation coefficient was used to evaluate the correlation between the gait analysis and the fat area fraction in muscle. All data are presented as mean 6 SD. Statistical significance was set at p < 0.05.
Results
Suprascapular Nerve Injury Was Induced by Compression and Reversed After Compression Release
The denervation group and the nerve compression group demonstrated more degenerating axons than the sham group. We observed 78% 6 18% (mean 6 SD) (95% confidence interval [CI], 55%-100%; p < 0.001 compared with sham) of degenerating axons in the denervation group and 58% 6 10% (95% CI, 45%-70%; p < 0.001 compared with sham) in the nerve compression group. However, for the nerve compression and release group, we only found 15% 6 9% (95% CI, 5%-26%) of axons with abnormal myelin, which was lower than the nerve compression group (p < 0.001). However, no difference was found when comparing the compression and release group with the sham group (p = 0.050; Fig. 3A-D) .
Compared with the sham group (ratio of disrupted neuromuscular junctions in the supraspinatus: 1% 6 0.18%, 95% CI, 1%-2%; in the infraspinatus: 1% 6 0.25%, 95% CI, 0.81%-1.42%), we found greater neuromuscular junction disruption (acetylcholine receptors with absence of neurofilament) in the denervation group (ratio of disrupted neuromuscular junctions in the supraspinatus: 93% 6 7%, 95% CI, 85%-102%, p < 0.001; in the infraspinatus: 87% 6 9%, 95% CI, 77%-98%, p < 0.001) and the nerve compression group (ratio of disrupted neuromuscular junctions in the supraspinatus: 71% 6 21%, 95% CI, 45%-97%, p < 0.001; in the infraspinatus: 65% 6 20%, 95% CI, 41%-90%, p < 0.001). However, we observed substantial neuromuscular junction recovery in the nerve compression and release group. No difference was found with the disrupted neuromuscular junctions between the sham group and the nerve compression and release group (ratio of disrupted neuromuscular junctions in the supraspinatus: 8% 6 7%, 95% CI, -0.12% to 16%, p = 0.052; in the infraspinatus: 11% 6 9%, 95% CI, 1%-22%, p = 0.0537) (Fig. 3E-L) . The denervation, nerve compression, and nerve compression and release groups had more muscle weight loss percentage and smaller muscle fiber cross-sectional area when compared with the sham group (for supraspinatus muscle weight loss percentage, the sham group: -2% 6 1%, 95%
CI, -3% to -0.2%; the denervation group: -48% 6 7%, 95% CI, -56% to -39%, p < 0.001; the nerve compression group: -41% 6 8%, 95% CI, -50% to -32%, p < 0.001; the nerve compression and release group: -20% 6 7%, 95% CI, -28% to -11%, p < 0.001; for infraspinatus muscle weight loss percentage, the sham group: -1% 6 1%, 95% CI, -3% to -0.12%; the denervation group: -46% 6 6%, 95% CI, -53% to -38%, p < 0.001; the nerve compression group: -41% 6 5%, 95% CI, -47% to -36%, p < 0.001; the nerve However, we found that the compression and release group demonstrated less muscle weight loss percentage and bigger muscle fiber cross-sectional area than the nerve compression group (supraspinatus muscle weight loss percentage, p = 0.001, infraspinatus, p = 0.001; supraspinatus muscle fiber cross-sectional area, p = 0.0098, infraspinatus, p = 0.0239) (Fig. 4) . Compared with the sham group (collagen area fraction in supraspinatus: 4% 6 2%, 95% CI, 2%-6%; collagen area fraction in infraspinatus: 3% 6 2%, 95% CI, 1%-5%; fat area fraction in supraspinatus: 2% 6 1%, 95% CI, 1%-3%; fat area fraction in infraspinatus: 2% 6 1%, 95% CI, 1%-2%), we observed more fibrosis and fatty infiltration in the supraspinatus and infraspinatus muscles from the denervation group (collagen area fraction in supraspinatus: 32% 6 4%, 95% CI, 27%-36%, p < 0.001 compared with sham; collagen area fraction in infraspinatus: 33% 6 3%, 95% CI, 30%-37%, p < 0.001 compared with sham; fat area fraction in supraspinatus: 20% 6 2%, 95% CI, 17%-23%, p < 0.001 compared with sham; fat area fraction in infraspinatus: 19% 6 3%, 95% CI, 15%-22%, p < 0.001 compared with sham) and the nerve compression group (collagen area fraction in supraspinatus: 26% 6 5%, 95% CI, 20%-31%, p < 0.001 compared with sham; collagen area fraction in infraspinatus: 25% 6 8%, 95% CI, 15%-35%, p < 0.001 compared with sham; fat area fraction in supraspinatus: 19% 6 1%, 95% CI, 18%-20%, p < 0.001 compared with sham; fat area fraction in infraspinatus: 17% 6 2%, 95% CI, 14%-20%, p < 0.001 compared with sham). However, compared with the nerve compression group, fibrosis and fatty infiltration were reduced in the nerve compression and release group (collagen area fraction in supraspinatus: 7% 6 2%, 95% CI, 4%-10%, p < 0.001; collagen area fraction in infraspinatus: 6% 6 3%, 95% CI, 2%-9%, p < 0.001; fat area fraction in supraspinatus: 5% 6 3%, 95% CI, 1%-10%, p < 0.001; fat area fraction in infraspinatus: 5% 6 3%, 95% CI, 1%-8%, p < 0.001) (Fig. 5) . Atrophy, fibrosis, and fatty infiltration-related gene expression were upregulated 3.5-to 4.5-fold in the denervation group and three-to fourfold in the nerve compression group. No major differences of atrophy, fibrosis, or fatty infiltration-related gene expression were found in the nerve compression and release group when compared with the sham group (Fig. 6) . Compared with the sham group (stride length: 3.06 6 0.52 cm, 95% CI, 2.42-3.71 cm; stance width: 1.62 6 0.16 cm, 95% CI, 1.42-1.82 cm; paw area at peak stance: 0.29 6 0.06 cm 2 , 95% CI, 0.22-0.37 cm 2 ), the injured limb function in the nerve compression and release group recovered 6 weeks after repair (stride length: 2.62 6 0.12 cm, 95% CI, 2.47-2.76 cm, p = 0.095; stance width: 1.55 6 0.12 cm, 95% CI, 1.40-1.70 cm, p = 0.436; paw area at peak stance: 0.26 6 0.03 cm 2 , 95% CI, 0.22-0.30 cm 2 , p = 0.2938). However, the injured limb function in animals in the denervation and nerve compression groups remained inferior to the sham group at 6 weeks postoperatively (for the denervation group, stride length: 1.80 6 0.52 cm, 95% CI, 1.15-2.45 cm, p = 0.0048; stance width: 1.18 6 0.15 cm, 95% CI, 0.99-1.37 cm, p = 0.002; paw area at peak stance: 0.16 6 0.04 cm 2 , 95% CI, 0.11-0.21 cm 2 , p = 0.003; for the nerve compression group, stride length: 2.11 6 0.24 cm, 95% CI, 1.81-2.41 cm, p = 0.0057; stance width: 1.27 6 0.08 cm, 95% CI, 1.17-1.37 cm, p = 0.002; paw area at peak stance: 0.19 6 0.03 cm 2 , 95% CI, 0.16-0.22 cm 2 , p = 0.007) (Fig. 7) . A correlation coefficient was applied to determine the correlation between the shoulder functional data (gait analysis) and the fat area fraction in the supraspinatus and infraspinatus muscles in the nerve compression and release group. For both the supraspinatus and infraspinatus muscles, fat area fraction showed a high correlation to stride length, stance width, and paw area at peak stance (for supraspinatus, r value of fat area fraction and stride length = -0.907, p = 0.033, r value of fat area fraction and stance width = -0.902, p = 0.036, r value of fat area fraction and paw area at peak stance = -0.983, p = 0.003; for infraspinatus, r value of fat area fraction and stride length = -0.950, p = 0.013, r value of fat area fraction and stance width = -0.912, p = 0.031, r value of fat area fraction and paw area at peak stance = -0.994, p = 0.001) ( Table 2) .
Muscle Fatty Infiltration After Suprascapular Nerve Compression and Release Is Related to Browning of White Fat
UCP1 expression was increased in the supraspinatus and infraspinatus of UCP1 reporter mice after undergoing 2 weeks of suprascapular nerve compression versus the contralateral side, but decreased at 2 weeks after release compared with nerve compression (ratio of UCP1 area in the supraspinatus, contralateral: 0.05% 6 0.02%, 95% CI, 0.02%-0.07%; nerve compression: 1.57% 6 0.21%, 95% CI, 1.31%-1.82%; versus contralateral, p < 0.001; nerve compression and release: 0.54% 6 0.51%, 95% CI, 0.09%-1.17%; versus contralateral, p = 0.063; versus nerve compression, p = 0.003; ratio of UCP1 area in the infraspinatus, contralateral: 0.03% 6 0.02%, 95% CI, 0.02%-0.05%; nerve compression: 1.63% 6 0.19%, 95% CI, 1.39%-1.87%; versus contralateral, p < 0.001; nerve compression and release: 0.52% 6 0.49%, 95% CI, -0.09% to 1.13%; versus contralateral, p = 0.056; versus nerve compression, p = 0.0016), suggesting robust beige fat development responding to suprascapular nerve injury (Fig. 8) .
Compared with 2-week suprascapular nerve compression in UCP1 (+/+) wild-type mice (collagen area fraction in supraspinatus: 4% 6 1%, 95% CI, 1%-7%; collagen area fraction in infraspinatus: 4% 6 1%, 95% CI, 3%-6%; fat area fraction in supraspinatus: 4% 6 0.27%, 95% CI, 3%-5%; fat area fraction in infraspinatus: 4% 6 1%, 95% CI, 3%-5%), fibrosis and fatty infiltration were reduced after nerve release in UCP1 (+/+) wild-type mice (collagen area fraction in supraspinatus: 2% 6 0.08%, 95% CI, 1.73%-2.13%, p = 0.044; collagen area fraction in infraspinatus: 2% 6 1%, 95% CI, 2%-3%, p = 0.024; fat area fraction in supraspinatus: 3% 6 0.32%, 95% CI, 2%-4%, p = 0.0079; fat area fraction in infraspinatus: 2% 6 1%, 95% CI, 1%-3%, p = 0.0228). However, compared with 2 weeks of suprascapular nerve compression in the UCP1 (+/+) wild-type mice, we observed more fibrosis and fatty infiltration in the supraspinatus and infraspinatus of the UCP1-KO mice after 2 weeks of nerve compression (collagen area fraction in supraspinatus: 9% 6 1%, 95% CI, 5%-12%, p = 0.011; collagen area fraction in infraspinatus: 9% 6 1%, 95% CI, 7%-10%, p < 0.001; fat area fraction in supraspinatus: 6% 6 1%, 95% CI, 4%-8%, p = 0.0106; fat area fraction in infraspinatus: 6% 6 2%, 95% CI, 4%-8%, p = 0.032). Moreover, for UCP1-KO mice, compared with suprascapular nerve compression, we observed no obvious fibrosis and fatty infiltration recovery at 2 weeks after nerve release (collagen area fraction in supraspinatus: 7% 6 1%, 95% CI, 6%-8%, p = 0.086; collagen area fraction in infraspinatus: 7% 6 2%, 95% CI, 5%-9%, p = 0.0916; fat area fraction in supraspinatus: 5% 6 0.32%, 95% CI, 4%-6%; p = 0.1095; fat area fraction in infraspinatus: 5% 6 1%, 95% CI, 4%-7%, p = 0.4047) (Fig. 9 ). This suggests that loss of UCP1 (+) beige fat worsens rotator cuff muscle fatty infiltration after suprascapular nerve compression and prevents fatty infiltration resorption after suprascapular nerve release. Gait analysis showed that stride length, stance width, and paw area at peak stance of the nerve compression and release group of UCP1-KO mice had reduced shoulder function when compared with the nerve compression and release group of wild-type mice (for wild-type mice, stride length: 2.17 6 0.37 cm, 95% CI, 1.71-2.63 cm; stance width: 1.24 6 0.15 cm, 95% CI, 1.05-1.43 cm; paw area at peak stance: 0.20 6 0.03 cm 2 , 95% CI, 0.16-0.24 cm 2 ; for UCP1-KO mice, stride length: 1.76 6 0.14 cm, 95% CI, 1.59-1.94 cm, p = 0.0489; stance width: 1.04 6 0.04 cm, 95% CI, 0.99-1.09 cm, p = 0.024; paw area at peak stance: 0.16 6 0.01 cm 2 , 95% CI, 0.15-0.18 cm 2 , p = 0.0399) (Fig. 10) .
Discussion
Suprascapular nerve neuropathy may contribute to shoulder dysfunction in patients with large and massive rotator cuff tears. After rotator cuff repair surgery, muscle fatty infiltration may remain and impair shoulder function. In their cadaveric study, Albritton et al. [1] showed that medial retraction of the supraspinatus tendon puts the nerve in tension by changing the angle between the nerve and its first motor branch. Clinical studies also imply a relationship between suprascapular neuropathy and retracted rotator cuff tears with recovery of nerve lesions and improvement of function and symptoms when the tears are repaired [8, 15, 33, 40] . However, the majority of current suprascapular denervation models have been made by nerve transection, which were not reversible. Nerve transection is acute and certainly is the most severe nerve injury, but it is not commonly seen in patients with rotator cuff tears. That being said, denervation Fig. 7 At 6 weeks postoperatively, gait analysis of the injured forelimb showed that the three parameters in the nerve compression and release group had recovered; however, the three parameters remained at a low level in the denervation group and nerve compression group when compared with the baseline and sham groups. Solid lines indicate p < 0.05 and dashed lines indicate p < 0.01. Error bars indicate SD. DN = denervation; NC = nerve compression; NCR = nerve compression and release. caused by nerve transection may not simulate the fallout from chronic suprascapular nerve injuries as seen in patients with typical rotator cuff tears. In this study, we developed a novel mouse model of reversible suprascapular nerve chronic compression. Compared with an acute suprascapular nerve transection model, this new model has two important improvements. First, suprascapular nerve neuropathy induced in this model is caused by compression rather than transection, which simulates the entrapment of the suprascapular nerve in massive rotator cuff tears. Second, this suprascapular nerve compression model allows recovery of the suprascapular nerve injury by surgically releasing the compression. In this study, we saw reinnervation of rotator cuff muscles after suprascapular nerve compression is released with concomitant muscle recovery. Compared with a nonrecoverable suprascapular nerve transection, this suprascapular nerve compression and release technique used in this new model allows researchers to study the rotator cuff muscle regeneration after suprascapular nerve neuropathy recovery.
This study has several limitations. First, the ligation location of the suprascapular nerve in this model is slightly different from where suprascapular nerve compression happens in massive rotator cuff tears. In the scenario of a large rotator cuff tear, the suprascapular nerve is compressed at the suprascapular notch beneath the supraspinatus muscle. However, in our model, it is impossible to reach the suprascapular notch without injuring the supraspinatus muscle. Thus, we compressed the suprascapular nerve at a higher level, just after it derives from the superior trunk of the brachial plexus. This allowed us to compress the suprascapular nerve without injuring the supraspinatus or infraspinatus muscles. Second, suprascapular nerve compression is not the only mechanism of suprascapular nerve injury after rotator tears. Retraction of rotator cuff muscle after complete tendon repair may also cause traction injury of the suprascapular nerve. Because both supraspinatus and infraspinatus tendons were intact, suprascapular nerve traction was not simulated in this model. Third, the process of suprascapular nerve compression in this model differs from the typical findings that are seen clinically in the presence of traction. Entrapment of the suprascapular nerve progresses slowly, taking months or years to develop in patients with massive rotator cuff tears. By contrast, in our model, suprascapular nerve compression was immediately and directly induced in our model after the wrapping was placed surgically. Another limitation was that only selective strains (UCP1 reporter, UCP-1 knockout, and C57B/L6J) of mice were used in this study. C57B/L6 is a commonly used wild-type strain, which are widely used in many orthopedic research studies. In our previous study, we successfully observed severe muscle atrophy and fatty infiltration after massive rotator cuff tendon tears [30] . UCP1 reporter (CD-1 background) and knockout mice (C57B/L6 background) that we used in this study are the only strains available to study UCP1 at this time. In our own literature search, we did not find strain differences in rotator cuff muscle atrophy and fatty infiltration after tendon or nerve injures. However, we will seek to confirm the findings made in this study by evaluating other strains of mice in the future. In addition, we predominantly used young female C57B/L6 mice in this study. It is known that rotator cuff tears are agerelated problems with incidence peaking after 40 years of age. The pathophysiology of the rotator cuff muscle after suprascapular nerve compression and release in young individuals may not be identical to those in older ones. Although we did not find sex differences in our pilot study, in future studies, we will recruit mice at different ages and of both sexes. Finally, as a result of the limited transgenic mouse numbers, we only used two time points for UCP1 reporter and knockout mice in this study. Future work with an extended time course will provide more detailed information regarding the involvement of beige fat in muscle fatty infiltration with suprascapular nerve compression and release.
Previous studies have been used botulinum toxin (Botox, Irvine, CA, USA) to study the role of denervation in muscle atrophy and degeneration in the setting of rotator cuff tears. Botulinum toxin selectively binds presynaptically to high-affinity recognition sites on the cholinergic nerve terminals, preventing the release of acetylcholine, which causes a neuromuscular blocking effect on the affected muscle 11. In a rabbit model of chronic rotator cuff tears, Gilotra et al. [14] found an injection of botulinum toxin worsened fatty infiltration in the supraspinatus muscle after tendon transection. Sato et al. [37] reported similar findings in a rat rotator cuff tear model. Although a previous study showed that supraspinatus muscle weight and volume slowly recover from botulinum toxin injection 6 months after tendon repair, muscle histology and function were not evaluated in that study [17] . Thus, it remains unclear if fatty infiltration induced by botulinum toxin in rotator cuff muscles is reversible over time. Compared with botulinum toxin injection, our suprascapular nerve compression and release model has two advantages. First, our model allows precise control for the timing of denervation and reinnervation of the supraspinatus and infraspinatus muscles with surgical Fig. 10 Gait analysis of the injured forelimb exhibits that stride length, stance width, and paw area at peak stance of the nerve compression and release group of UCP1-KO mice had reduced shoulder function when compared with the nerve compression and release group of wild-type mice. Solid lines indicate p < 0.05 and dashed lines indicate p < 0.01. Error bars indicate SD. DN = denervation; NC = nerve compression; NCR = nerve compression and release.
Volume 476, Number 8 compression and release of the suprascapular nerve. The second advantage, which may be more interesting, is that we observed fast resorption of fatty infiltration in the rotator cuff muscle after suprascapular nerve-releasing compression.
Muscle fatty infiltration is generally considered irreversible, and advanced muscle fatty infiltration is a marker of end-stage rotator cuff disease. Currently, patients with severe muscle fatty infiltration (Goutallier Grade 3 or 4) are not considered good candidates for surgical repair as a result of the high failure rate of tendon repair. Previous preclinical studies with various animal rotator cuff tear models, including our own work with rats [10, 21, 29, 31] and mice [30, 32, 36] , also demonstrated irreversible supraspinatus and/or infraspinatus muscle fatty infiltration after tendon and/or nerve injuries. However, in this current study, we observed fat resorption in the supraspinatus and infraspinatus muscles after the release of suprascapular nerve compression. This exciting finding challenges the traditional concept of irreversible rotator cuff muscle fatty infiltration. If suprascapular nerve decompression does reverse muscle fatty infiltration, many patients with Goutallier Grade 3 and 4 muscle fatty infiltration may be qualified for surgical rotator cuff repair through nerve release.
The detailed underlying cellular and molecular mechanisms of muscle fatty infiltration resorption after suprascapular nerve compression remain undefined. However, results from our UCP1 reporter and knockout mice suggest that browning of white fat may be an important mechanism of rotator cuff muscle fatty infiltration resorption. Recently, browning of white fat has become a potential therapeutic intervention to treat obesity and metabolic diseases. Many browning reagents have been discovered and tested. Some of these browning reagents are FDAapproved drugs currently used in the clinic for other indications [7, 41] . For example, PPARg agonists, thiazolidinediones, are currently used to treat diabetes. A b3-adrenergic receptor agonist, mirabegron, is currently used to treat an overactive bladder. Those white fat browning reagents may serve as future treatments for rotator cuff muscle fatty infiltration.
Regardless of muscle or tendon morphology, one of the most important clinical outcomes for rotator cuff tear repair/rehabilitation is shoulder function. Unlike patients with rotator cuff tears, it is difficult to apply the active joint ROM or other shoulder function testing methods that we use in the clinic to mice. In this study, we adopted a forced downhill running upper limb gait analysis to measure shoulder function in mice. This method has been used for evaluating shoulder function after rotator cuff tears repair 6. In this study, we found that downhill running gait analysis with DigiGait was highly reproducible and consistent among animals within groups. It is also interesting that the gait reduction correlated well with the amount of fat in rotator cuff muscles. These data suggest that forced downhill running upper limb gait analysis is a reliable measurement for shoulder function in mice. It also suggests that rotator cuff muscle fatty infiltration is an important factor for shoulder function.
In summary, we successfully developed a clinically relevant reversible suprascapular nerve compression mouse model. We observed consistent muscle fatty infiltration after nerve compression as well as fatty infiltration resorption after compression release. Future studies will explore how a repair model in combination with nerve compression/release will affect muscle quality and serve as a proxy for studying clinical outcomes as they relate to muscle function. Data from UCP1 reporter and knockout mice suggest that brown/beige fat may play an important role in muscle fatty infiltration resorption after nerve compression release. The mechanism of white fat browning in rotator cuff muscle fatty infiltration and resorption needs to be studied in larger animals and humans to improve clinical outcomes after rotator cuff repair. Given the abundant presence of fibro-/adipogenic progenitor cells after rotator cuff injury, it stands to reason that these cells can be leveraged to transition to beige fat and improve muscle quality after rotator cuff repair. Future studies evaluating pharmacologic treatments to improve "browning" of fibro-/adipogenic progenitor cells will help determine the efficacy of this treatment strategy.
